These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 7783140)

  • 1. Receptor surface models. 2. Application to quantitative structure-activity relationships studies.
    Hahn M; Rogers D
    J Med Chem; 1995 Jun; 38(12):2091-102. PubMed ID: 7783140
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Receptor dependent multidimensional QSAR for modeling drug--receptor interactions.
    Polanski J
    Curr Med Chem; 2009; 16(25):3243-57. PubMed ID: 19548875
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Using molecular docking, 3D-QSAR, and cluster analysis for screening structurally diverse data sets of pharmacological interest.
    Santos-Filho OA; Cherkasov A
    J Chem Inf Model; 2008 Oct; 48(10):2054-65. PubMed ID: 18816024
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Three- and four-dimensional quantitative structure activity relationship analyses of cytochrome P-450 3A4 inhibitors.
    Ekins S; Bravi G; Binkley S; Gillespie JS; Ring BJ; Wikel JH; Wrighton SA
    J Pharmacol Exp Ther; 1999 Jul; 290(1):429-38. PubMed ID: 10381809
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Whither combine? New opportunities for receptor-based QSAR.
    Lushington GH; Guo JX; Wang JL
    Curr Med Chem; 2007; 14(17):1863-77. PubMed ID: 17627522
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative molecular moment analysis (CoMMA): 3D-QSAR without molecular superposition.
    Silverman BD; Platt DE
    J Med Chem; 1996 May; 39(11):2129-40. PubMed ID: 8667357
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Three- and four-dimensional-quantitative structure activity relationship (3D/4D-QSAR) analyses of CYP2C9 inhibitors.
    Ekins S; Bravi G; Binkley S; Gillespie JS; Ring BJ; Wikel JH; Wrighton SA
    Drug Metab Dispos; 2000 Aug; 28(8):994-1002. PubMed ID: 10901712
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multi-dimensional QSAR in drug research. Predicting binding affinities, toxicity and pharmacokinetic parameters.
    Vedani A; Dobler M
    Prog Drug Res; 2000; 55():105-35. PubMed ID: 11127962
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Three-dimensional structure-activity relationships and receptor mapping of N1-substituents of quinolone antibacterials.
    Ohta M; Koga H
    J Med Chem; 1991 Jan; 34(1):131-9. PubMed ID: 1992111
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantitative structure activity relationship (QSAR) studies on nitazoxanide-based analogues against Clostridium difficile In vitro.
    Zhang H; Liu X; Yang Y; Li J
    Pak J Pharm Sci; 2016 Sep; 29(5):1681-1689. PubMed ID: 27731829
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improving the quality of 3D-QSAR by using flexible-ligand receptor models.
    Pei J; Chen H; Liu Z; Han X; Wang Q; Shen B; Zhou J; Lai L
    J Chem Inf Model; 2005; 45(6):1920-33. PubMed ID: 16309299
    [TBL] [Abstract][Full Text] [Related]  

  • 12. How good are ensembles in improving QSAR models? The case with eCoRIA.
    Khedkar VM; Joseph J; Pissurlenkar R; Saran A; Coutinho EC
    J Biomol Struct Dyn; 2015; 33(4):749-69. PubMed ID: 24754910
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exploring 3D-QSAR of thiazole and thiadiazole derivatives as potent and selective human adenosine A3 receptor antagonists+.
    Bhattacharya P; Leonard JT; Roy K
    J Mol Model; 2005 Nov; 11(6):516-24. PubMed ID: 15928917
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative receptor surface analysis of octopaminergic antagonists for the locust neuronal octopamine receptor.
    Hirashima A; Kuwano E; Eto M
    Comput Biol Chem; 2003 Dec; 27(6):531-40. PubMed ID: 14667781
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exploring QSAR and QAAR for inhibitors of cytochrome P450 2A6 and 2A5 enzymes using GFA and G/PLS techniques.
    Roy K; Roy PP
    Eur J Med Chem; 2009 May; 44(5):1941-51. PubMed ID: 19110342
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Free-energy force-field three-dimensional quantitative structure-activity relationship analysis of a set of p38-mitogen activated protein kinase inhibitors.
    Romeiro NC; Albuquerque MG; de Alencastro RB; Ravi M; Hopfinger AJ
    J Mol Model; 2006 Sep; 12(6):855-68. PubMed ID: 16541250
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A 3D-QSAR study on the structural requirements for binding to CB(1) and CB(2) cannabinoid receptors.
    Fichera M; Cruciani G; Bianchi A; Musumarra G
    J Med Chem; 2000 Jun; 43(12):2300-9. PubMed ID: 10882356
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantitative structure activity relationship and pharmacophore studies of adenosine receptor A2B inhibitors.
    Joseph TB; Suneel Kumar BV; Santhosh B; Kriti S; Pramod AB; Ravikumar M; Kishore M
    Chem Biol Drug Des; 2008 Nov; 72(5):395-408. PubMed ID: 19012575
    [TBL] [Abstract][Full Text] [Related]  

  • 19. QSAR studies of CYP2D6 inhibitor aryloxypropanolamines using 2D and 3D descriptors.
    Roy PP; Roy K
    Chem Biol Drug Des; 2009 Apr; 73(4):442-55. PubMed ID: 19291105
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Application of GA-MLR for QSAR Modeling of the Arylthioindole Class of Tubulin Polymerization Inhibitors as Anticancer Agents.
    Ahmadi S; Habibpour E
    Anticancer Agents Med Chem; 2017; 17(4):552-565. PubMed ID: 27528182
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.